These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 19788245)
21. Lycorine and its derivatives for anticancer drug design. Lamoral-Theys D; Decaestecker C; Mathieu V; Dubois J; Kornienko A; Kiss R; Evidente A; Pottier L Mini Rev Med Chem; 2010 Jan; 10(1):41-50. PubMed ID: 20105122 [TBL] [Abstract][Full Text] [Related]
22. Lycorine and homolycorine derivatives for chemo-sensitizing resistant human ovarian adenocarcinoma cells. Sancha SAR; Dobiasová S; Nejedlý T; Strnad O; Viktorová J; Ferreira MU Phytomedicine; 2024 Apr; 126():155460. PubMed ID: 38394731 [TBL] [Abstract][Full Text] [Related]
23. Novel lycorine derivatives as anticancer agents: synthesis and in vitro biological evaluation. Wang P; Yuan HH; Zhang X; Li YP; Shang LQ; Yin Z Molecules; 2014 Feb; 19(2):2469-80. PubMed ID: 24566315 [TBL] [Abstract][Full Text] [Related]
24. Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas. Van Goietsenoven G; Hutton J; Becker JP; Lallemand B; Robert F; Lefranc F; Pirker C; Vandenbussche G; Van Antwerpen P; Evidente A; Berger W; Prévost M; Pelletier J; Kiss R; Kinzy TG; Kornienko A; Mathieu V FASEB J; 2010 Nov; 24(11):4575-84. PubMed ID: 20643906 [TBL] [Abstract][Full Text] [Related]
25. Identification of molecular anti-metastasis mechanisms of lycorine in colorectal cancer by RNA-seq analysis. Gao L; Feng Y; Ge C; Xu X; Wang S; Li X; Zhang K; Wang C; Dai F; Xie S Phytomedicine; 2021 May; 85():153530. PubMed ID: 33761445 [TBL] [Abstract][Full Text] [Related]
26. Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells. Govindaraju K; Ingels A; Hasan MN; Sun D; Mathieu V; Masi M; Evidente A; Kornienko A Bioorg Med Chem Lett; 2018 Feb; 28(4):589-593. PubMed ID: 29409754 [TBL] [Abstract][Full Text] [Related]
27. Mannosylated lipid nano-emulsions loaded with lycorine-oleic acid ionic complex for tumor cell-specific delivery. Guo Y; Liu X; Sun X; Zhang Q; Gong T; Zhang Z Theranostics; 2012; 2(11):1104-14. PubMed ID: 23227126 [TBL] [Abstract][Full Text] [Related]
28. Lycorine induces apoptosis of bladder cancer T24 cells by inhibiting phospho-Akt and activating the intrinsic apoptotic cascade. Wang C; Wang Q; Li X; Jin Z; Xu P; Xu N; Xu A; Xu Y; Zheng S; Zheng J; Liu C; Huang P Biochem Biophys Res Commun; 2017 Jan; 483(1):197-202. PubMed ID: 28042037 [TBL] [Abstract][Full Text] [Related]
29. Lycorine inhibits breast cancer growth and metastasis via inducing apoptosis and blocking Src/FAK-involved pathway. Ying X; Huang A; Xing Y; Lan L; Yi Z; He P Sci China Life Sci; 2017 Apr; 60(4):417-428. PubMed ID: 28251459 [TBL] [Abstract][Full Text] [Related]
30. Lycorine (Lycoris radiata)-a unique natural medicine on breast cancer. Xue Q; Wang B; Feng J; Li C; Yu M; Zhao Y; Qi Z J Cell Mol Med; 2024 Aug; 28(16):e70032. PubMed ID: 39175104 [TBL] [Abstract][Full Text] [Related]
31. Acetylcholinesterase inhibition within the lycorine series of Amaryllidaceae alkaloids. Nair JJ; van Staden J Nat Prod Commun; 2012 Jul; 7(7):959-62. PubMed ID: 22908593 [TBL] [Abstract][Full Text] [Related]
32. Lycorine inhibits cell proliferation and induced oxidative stress-mediated apoptosis via regulation of the JAK/STAT3 signaling pathway in HT-3 cells. Shang H; Jang X; Shi L; Ma Y J Biochem Mol Toxicol; 2021 Oct; 35(10):e22882. PubMed ID: 34558146 [TBL] [Abstract][Full Text] [Related]
33. Lycorine inhibited the cell growth of non-small cell lung cancer by modulating the miR-186/CDK1 axis. Li L; Zhang Z; Yang Q; Ning M Life Sci; 2019 Aug; 231():116528. PubMed ID: 31176784 [TBL] [Abstract][Full Text] [Related]
34. Narciclasine, a plant growth modulator, activates Rho and stress fibers in glioblastoma cells. Lefranc F; Sauvage S; Van Goietsenoven G; Mégalizzi V; Lamoral-Theys D; Debeir O; Spiegl-Kreinecker S; Berger W; Mathieu V; Decaestecker C; Kiss R Mol Cancer Ther; 2009 Jul; 8(7):1739-50. PubMed ID: 19531573 [TBL] [Abstract][Full Text] [Related]
35. Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers. Van Goietsenoven G; Mathieu V; Lefranc F; Kornienko A; Evidente A; Kiss R Med Res Rev; 2013 Mar; 33(2):439-55. PubMed ID: 22419031 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and antiplasmodial activity of lycorine derivatives. Cedrón JC; Gutiérrez D; Flores N; Ravelo AG; Estévez-Braun A Bioorg Med Chem; 2010 Jul; 18(13):4694-701. PubMed ID: 20627737 [TBL] [Abstract][Full Text] [Related]
37. Design, Synthesis, and Structural Optimization of Lycorine-Derived Phenanthridine Derivatives as Wnt/β-Catenin Signaling Pathway Agonists. Chen DZ; Jing CX; Cai JY; Wu JB; Wang S; Yin JL; Li XN; Li L; Hao XJ J Nat Prod; 2016 Jan; 79(1):180-8. PubMed ID: 26714198 [TBL] [Abstract][Full Text] [Related]
38. Anti-dengue-virus activity and structure-activity relationship studies of lycorine derivatives. Wang P; Li LF; Wang QY; Shang LQ; Shi PY; Yin Z ChemMedChem; 2014 Jul; 9(7):1522-33. PubMed ID: 24574246 [TBL] [Abstract][Full Text] [Related]
39. Lycorine ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3 inflammasome activation and pyroptosis. Liang Q; Cai W; Zhao Y; Xu H; Tang H; Chen D; Qian F; Sun L Pharmacol Res; 2020 Aug; 158():104884. PubMed ID: 32428667 [TBL] [Abstract][Full Text] [Related]
40. Design, Synthesis and Structure-Activity Relationship Optimization of Lycorine Derivatives for HCV Inhibition. Chen D; Cai J; Cheng J; Jing C; Yin J; Jiang J; Peng Z; Hao X Sci Rep; 2015 Oct; 5():14972. PubMed ID: 26443922 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]